Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Extracellular Vesicles 2023: Technologies, Biomarker Cargo & Diagnostics

Yong Zeng's Biography



Yong Zeng, Associate Professor, Department of Chemistry, University of Florida

Dr. Zeng is an associate professor of chemistry and affiliate faculty of Biomedical Engineering at the University of Florida, and a member of UF Health Cancer Center. Dr. Zeng’s research draws on chemistry, nanomaterials, bioengineering, and medicine to develop innovative micro and nanoscale tools to advance precision medicine of cancer. His technology innovations span from biomolecular assays to micro/nano systems for sensitive measurements of liquid biopsies and molecular biomarkers. His group is also devoted to translational research to bring the technological innovations to clinical sciences, closely collaborating with biologists and clinicians. Dr. Zeng is internationally recognized for his pioneering research in developing microfluidic technologies for isolation and analysis of tumor-derived extracellular vesicles (EVs) for cancer diagnostics and therapeutics. His research programs have been continuously funded by NIH and other funding agencies and led to many highly visible publications in top-tier journals, including Nat. Biomed. Eng. and Sci. Transl. Med., which were featured in public media outlets such as the NIH Director’s Blog and the JAMA Network.

Yong Zeng Image

Extracellular Vesicles-Enabled Liquid Biopsy for Cancer Diagnosis, Prognosis, and Treatment

Wednesday, 26 July 2023 at 16:30

Add to Calendar ▼2023-07-26 16:30:002023-07-26 17:30:00Europe/LondonExtracellular Vesicles-Enabled Liquid Biopsy for Cancer Diagnosis, Prognosis, and TreatmentExtracellular Vesicles 2023: Technologies, Biomarker Cargo and Diagnostics in Orlando, FloridaOrlando, FloridaSELECTBIOenquiries@selectbiosciences.com

My research is primarily focused on the development of innovative liquid biopsy-based tests based on extracellular vesicles (EVs) and micro/nanobiosensing technologies for cancer diagnosis, prognosis, and treatment. Herein, we will discuss the nanoengineered systems and bioassays for efficient immunoisolation of circulating EVs and ultrasensitive profiling of EV biomarkers, including proteins and miRNAs.  Adaptation of our new technologies to clinical assessment of EV-based liquid biopsy for non-invasive detection, subtyping, and treatment monitoring of cancer will be demonstrated.


Add to Calendar ▼2023-07-26 00:00:002023-07-27 00:00:00Europe/LondonExtracellular Vesicles 2023: Technologies, Biomarker Cargo and DiagnosticsExtracellular Vesicles 2023: Technologies, Biomarker Cargo and Diagnostics in Orlando, FloridaOrlando, FloridaSELECTBIOenquiries@selectbiosciences.com